...
首页> 外文期刊>Clinical and experimental hypertension: CEH >Vascular endothelial growth factor polymorphism (-460 T/C) is related to hypertension-associated chronic kidney disease
【24h】

Vascular endothelial growth factor polymorphism (-460 T/C) is related to hypertension-associated chronic kidney disease

机译:血管内皮生长因子多态性(-460 T / C)与高血压相关的慢性肾脏疾病有关

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Our aim was to characterize the endothelial progenitor cells (EPCs) in normotensive controls and treated hypertensive individuals within the vascular endothelial growth factor (VEGF) -460 C/T polymorphism as well as to investigate whether this polymorphism predisposes to hypertension-related chronic kidney disease. The hypertensive patients bearing the TT genotype had the highest levels of immature EPC with the following phenotypes: CD34(+), CD34(+)CD45(dim), CD34(+)CD133(+)CD45(dim). The study showed the estimated glomerular filtration rate values significantly lower and creatinine and BUN parameters higher among the TT hypertensive patients. We presume that the highest mobilization of EPCs from bone marrow may signalize more severe renal hypertension-related complications in the VEGF -460 TT genotype.
机译:我们的目的是表征正常对照和血管内皮生长因子(VEGF)-460 C / T多态性内的高血压个体的内皮祖细胞(EPC),并研究该多态性是否易患高血压相关的慢性肾脏疾病。具有TT基因型的高血压患者未成熟EPC的水平最高,其表型为:CD34(+),CD34(+)CD45(dim),CD34(+)CD133(+)CD45(dim)。该研究表明,TT高血压患者的估计肾小球滤过率值明显较低,而肌酐和BUN参数较高。我们假设从骨髓中动员的EPC最高,可能预示着VEGF -460 TT基因型中更严重的与高血压相关的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号